Format

Send to

Choose Destination
Clin Infect Dis. 2015 Jun 1;60(11):1726-8. doi: 10.1093/cid/civ130. Epub 2015 Feb 19.

Oral Bacitracin: A Consideration for Suppression of Intestinal Vancomycin-Resistant Enterococci (VRE) and for VRE Bacteremia From an Apparent Gastrointestinal Tract Source.

Author information

1
Division of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston University of Houston College of Pharmacy.
2
Department of Pharmacy, Baylor St Luke's Medical Center, Houston, Texas.
3
Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
4
Division of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston Universidad El Bosque, Bogotá, Colombia.
5
University of Houston College of Pharmacy Department of Microbiology and Molecular Genetics, University of Texas Health Science Center at Houston.
PMID:
25697741
PMCID:
PMC4447780
DOI:
10.1093/cid/civ130
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center